Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Operating Leases: 2018-2024

Historic Operating Leases for CureVac N.V (CVAC) over the last 7 years, with Dec 2024 value amounting to $41.6 million.

  • CureVac N.V's Operating Leases fell 7.47% to $41.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $41.6 million, marking a year-over-year decrease of 7.47%. This contributed to the annual value of $41.6 million for FY2024, which is 7.47% down from last year.
  • Latest data reveals that CureVac N.V reported Operating Leases of $41.6 million as of FY2024, which was down 7.47% from $45.0 million recorded in FY2023.
  • Over the past 5 years, CureVac N.V's Operating Leases peaked at $45.0 million during FY2023, and registered a low of $33.1 million during FY2021.
  • For the 3-year period, CureVac N.V's Operating Leases averaged around $43.2 million, with its median value being $42.9 million (2022).
  • As far as peak fluctuations go, CureVac N.V's Operating Leases skyrocketed by 129.36% in 2020, and later fell by 7.86% in 2021.
  • Yearly analysis of 5 years shows CureVac N.V's Operating Leases stood at $35.9 million in 2020, then decreased by 7.86% to $33.1 million in 2021, then increased by 29.91% to $42.9 million in 2022, then grew by 4.80% to $45.0 million in 2023, then declined by 7.47% to $41.6 million in 2024.